Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$56.94 USD

56.94
5,112,835

+0.47 (0.83%)

Updated Sep 10, 2024 04:00 PM ET

After-Market: $56.89 -0.05 (-0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (235 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Shaun Pruitt headshot

Time to Buy CVS Stock Before Crucial Q4 Earnings?

Trading near its 52-week lows and 23% from its highs, investors will be paying close attention to CVS Health's (CVS) fourth-quarter earnings on February 8.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $86.18 in the latest trading session, marking a -1.5% move from the prior day.

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health (CVS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Zacks Analyst Blog Highlights Apple, Meta Platforms, Mastercard, CVS Health and Ameriprise Financial

Apple, Meta Platforms, Mastercard, CVS Health and Ameriprise Financial are included in this Analyst Blog.

Sheraz Mian headshot

Q4 Earnings Season Scorecard and Analyst Reports for Apple, Meta & Mastercard

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Meta Platforms, Inc. (META) and Mastercard Incorporated (MA).

Here's Why CVS Health (CVS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed at $87.78 in the latest trading session, marking a +0.14% move from the prior day.

CVS Health (CVS) to Report Q4 Earnings: What's in the Cards?

CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q4.

CVS Health (CVS) to Expand Health Care Access With New Pact

CVS Health's (CVS) recent collaboration establishes new Accountable Care that focuses on health equity, coordinated care and enhanced access.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon

CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon are part of the Zacks Industry Outlook article.

Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?

According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Headwinds

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain despite reimbursement challenges hurting the overall industry health.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed the most recent trading day at $87, moving -0.55% from the previous trading session.

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Shaun Pruitt headshot

Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?

News of CVS Health (CVS) potentially acquiring Oak Street Health (OHS) for $10 billion broke this week and highlighted what could be another lucrative acquisition in 2023.

Shaun Pruitt headshot

5 Retail Stocks That Could Rally on Lower Inflation

Consumer data showing signs of deflation on a month-to-month basis is promising for the broader stock market. This is especially significant for the Retail and Wholesale sector and a stronger consumer could lead to more upside in these five stocks.

The Zacks Analyst Blog Highlights JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx

JPMorgan Chase, Chevron, Salesforce, CVS Health and FedEx are included in this Analyst Blog.

CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know

CVS Health (CVS) closed at $89.75 in the latest trading session, marking a -0.99% move from the prior day.

Mark Vickery headshot

Top Research Reports for JPMorgan Chase, Chevron & Salesforce

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Chevron Corporation (CVX) and Salesforce, Inc. (CRM).

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Mark Vickery headshot

World Bank Sees Slow Growth in 2023

The World Bank has slashed its 2023 growth projection from to +1.7% from +3% it just six short months ago.